Rajni Sinha, MD – Piedmont Cancer Institute

Rajni Sinha, MD - Piedmont Cancer Institute is a medical doctor in Atlanta, Georgia, specializing in oncology and hematology. She provides care for patients with cancer and blood disorders across multiple locations in metro-Atlanta, including Atlanta, Sandy Springs, Fayetteville, Locust Grove, Newnan, and Stockbridge. Her clinical focus includes solid tumors such as breast cancer, hepatobiliary and gastrointestinal cancers, and hematological malignancies. Dr. Sinha is a board-certified medical oncologist and hematologist with experience as a principal investigator in industry-sponsored and investigator-initiated clinical trials. She has authored or co-authored publications in oncology and is a presenting speaker at national conferences. She returned to Atlanta in 2016 after practicing in Chattanooga and is affiliated with the American Society of Clinical Oncology, the American Society of Hematology, and the American Medical Association.

Dr. Sinha is part of the Piedmont Cancer Institute team, which emphasizes compassionate care, innovation, and community. The institute’s research staff actively participates in phase 2, 3, and 4 clinical trials, offering patients access to emerging therapies. These trials are conducted in collaboration with major pharmaceutical companies and aim to improve outcomes and life expectancy for cancer patients. The institute supports patients through clinical research, treatment, and prevention services across its network of locations.

The Atlanta office is located on Howell Mill Road Northwest, situated just a short distance from the Horace E Tate Freeway and the United States Post Office. Nearby landmarks include Old Mt. Zion Church, Buckhead Primary and Urgent Care Clinic, and Piedmont West Surgery Center, all within a quarter mile. The office is positioned along a major road in the Buckhead area, accessible from nearby interstates and local transit routes.

Dr. Sinha is recognized for her expertise in clinical research and her commitment to advancing cancer care. Her professional affiliations and participation in national conferences reflect her standing as a dedicated practitioner in the field of oncology. She is known for integrating the latest treatments into patient care through active involvement in clinical trial development and implementation.